APO Research
Talk to an analyst

APO RESEARCH · REPORT

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8)

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is a nitrogen-containing chemical substance or reagent identified by its named structure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Functional groups, isomer identity, salt or free-base form, assay and impurity profile distinguish the material. Product-specific compatibility and handling must come from the relevant specification and documentation.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which identity, supplied form and impurity specification are required?

Functional groups, isomer identity, salt or free-base form, assay and impurity profile distinguish the material. Product-specific compatibility and handling must come from the relevant specification and documentation.

Selected research

Market Structure

Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry Research3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) include Ningbo Innopharmchem, Manus Aktteva Biopharma, Hefei Home Sunshine Pharmaceutical, Nantong Zandery BioTechnology, Changzhou An Peng Chemical, Changzhou uniringchem, Huateng Pharmaceuticals, Shanghai Send Pharmaceutical and Pharmaffiliates Analytics & Synthetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market size, projected growth trends, production technologies, key applications, and end-use industries.

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Company

Ningbo Innopharmchem

Manus Aktteva Biopharma

Hefei Home Sunshine Pharmaceutical

Nantong Zandery BioTechnology

Changzhou An Peng Chemical

Changzhou uniringchem

Huateng Pharmaceuticals

Shanghai Send Pharmaceutical

Pharmaffiliates Analytics & Synthetics

Biosynth Carbosynth

ChemScene

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Purity

97% Purity

98% Purity

Others

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Application

Pharmaceutical Intermediates

Organic Synthesis

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) industry.

Chapter 3: Detailed analysis of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market competition landscape. Including 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Trends Table 2. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Drivers Table 3. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Opportunities and Challenges Table 4. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Restraints Table 5. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Manufacturers (2021-2026) Table 7. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Manufacturers (Kg) & (2021-2026) Table 8. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Manufacturers Table 9. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers, Product Type & Application Table 13. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of 97% Purity Table 17. Major Manufacturers of 98% Purity Table 18. Major Manufacturers of Others Table 19. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type (2021-2026) & (Kg) Table 21. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type (2027-2032) & (Kg) Table 22. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Type (2021-2026) Table 23. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Type (2027-2032) Table 24. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type (2021-2026) & (Kg) Table 26. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type (2027-2032) & (Kg) Table 27. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Type (2021-2026) Table 28. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceutical Intermediates Table 30. Major Manufacturers of Organic Synthesis Table 31. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021-2026) & (Kg) Table 33. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2027-2032) & (Kg) Table 34. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2026) Table 35. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2027-2032) Table 36. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021-2026) & (Kg) Table 38. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2027-2032) & (Kg) Table 39. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2021-2026) Table 40. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2027-2032) Table 41. Ningbo Innopharmchem Company Information Table 42. Ningbo Innopharmchem Business Overview Table 43. Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 44. Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 45. Ningbo Innopharmchem Recent Development Table 46. Manus Aktteva Biopharma Company Information Table 47. Manus Aktteva Biopharma Business Overview Table 48. Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 49. Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 50. Manus Aktteva Biopharma Recent Development Table 51. Hefei Home Sunshine Pharmaceutical Company Information Table 52. Hefei Home Sunshine Pharmaceutical Business Overview Table 53. Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 54. Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 55. Hefei Home Sunshine Pharmaceutical Recent Development Table 56. Nantong Zandery BioTechnology Company Information Table 57. Nantong Zandery BioTechnology Business Overview Table 58. Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 59. Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 60. Nantong Zandery BioTechnology Recent Development Table 61. Changzhou An Peng Chemical Company Information Table 62. Changzhou An Peng Chemical Business Overview Table 63. Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 64. Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 65. Changzhou An Peng Chemical Recent Development Table 66. Changzhou uniringchem Company Information Table 67. Changzhou uniringchem Business Overview Table 68. Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 70. Changzhou uniringchem Recent Development Table 71. Huateng Pharmaceuticals Company Information Table 72. Huateng Pharmaceuticals Business Overview Table 73. Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 75. Huateng Pharmaceuticals Recent Development Table 76. Shanghai Send Pharmaceutical Company Information Table 77. Shanghai Send Pharmaceutical Business Overview Table 78. Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 80. Shanghai Send Pharmaceutical Recent Development Table 81. Pharmaffiliates Analytics & Synthetics Company Information Table 82. Pharmaffiliates Analytics & Synthetics Business Overview Table 83. Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 85. Pharmaffiliates Analytics & Synthetics Recent Development Table 86. Biosynth Carbosynth Company Information Table 87. Biosynth Carbosynth Business Overview Table 88. Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 90. Biosynth Carbosynth Recent Development Table 91. ChemScene Company Information Table 92. ChemScene Business Overview Table 93. ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 95. ChemScene Recent Development Table 96. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021 VS 2025 VS 2032 (Kg) Table 97. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region (2021-2026) & (Kg) Table 98. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Region (2021-2026) Table 99. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Forecast by Region (2027-2032) & (Kg) Table 100. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share Forecast by Region (2027-2032) Table 101. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 102. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2021-2026) & (US$ Million) Table 103. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Region (2021-2026) Table 104. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2027-2032) & (US$ Million) Table 105. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Region: (2027-2032) & (US$ Million) Table 106. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (US$/Kg) by Region (2021-2026) Table 107. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (US$/Kg) by Region (2027-2032) Table 108. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region: 2021 VS 2025 VS 2032 (Kg) Table 109. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2021-2026) & (Kg) Table 110. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Region (2021-2026) Table 111. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Forecasted by Region (2027-2032) & (Kg) Table 112. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Forecasted Market Share by Region (2027-2032) Table 113. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 114. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 115. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 116. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 117. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 118. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 119. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 120. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 121. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 122. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 123. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 124. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 125. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 126. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 127. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Distributors List Table 131. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Image Figure 2. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 4. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity (2021-2032) & (Kg) Figure 5. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (2021-2032) & (Kg) Figure 6. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price (US$/Kg) & (2021-2032) Figure 7. Global Top 5 and 10 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 97% Purity Image Figure 10. 98% Purity Image Figure 11. Others Image Figure 12. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Type (2021-2032) Figure 15. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type (2021 VS 2025 VS 2032) & (Kg) Figure 16. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Type (2021-2032) Figure 18. Pharmaceutical Intermediates Image Figure 19. Organic Synthesis Image Figure 20. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share 2021 VS 2025 VS 2032 Figure 22. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2032) Figure 23. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share 2021 VS 2025 VS 2032 Figure 25. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Application (2021-2032) Figure 26. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 31. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 33. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 35. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 36. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 37. U.S. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 38. Canada 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 39. Mexico 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 40. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 41. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 42. Germany 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 43. France 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 44. U.K. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 45. Italy 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 46. Netherlands 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 47. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 48. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 49. China 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 50. Japan 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 51. South Korea 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 52. Southeast Asia 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 53. India 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 54. Australia 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 55. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 56. South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 57. Brazil 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 58. Argentina 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 59. Chile 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 60. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 61. Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 62. Egypt 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 63. South Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 64. Israel 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 65. Türkiye 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 66. GCC Countries 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 67. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 97% Purity
  • 98% Purity
  • Others
Applications
  • Pharmaceutical Intermediates
  • Organic Synthesis
Companies covered
  • Ningbo Innopharmchem
  • Manus Aktteva Biopharma
  • Hefei Home Sunshine Pharmaceutical
  • Nantong Zandery BioTechnology
  • Changzhou An Peng Chemical
  • Changzhou uniringchem
  • Huateng Pharmaceuticals
  • Shanghai Send Pharmaceutical
  • Pharmaffiliates Analytics & Synthetics
  • Biosynth Carbosynth
  • ChemScene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Dynamics
  1. 2.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Trends
  2. 2.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Drivers
  3. 2.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Opportunities and Challenges
  4. 2.4 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Restraints
3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Manufacturers
  1. 3.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Manufacturers (2021-2026)
  2. 3.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Manufacturers (2021-2026)
  3. 3.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers, Product Type & Application
  7. 3.7 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Players Market Share by Production Value in 2025
  11. 3.8.3 2025 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Tier 1, Tier 2, and Tier 3
4 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Type
  1. 4.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Type Introduction
  2. 4.1.1 97% Purity
  3. 4.1.2 98% Purity
  4. 4.1.3 Others
  5. 4.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type
  6. 4.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Type (2021-2032)
  8. 4.2.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Type (2021-2032)
  9. 4.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type
  10. 4.3.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Type (2021-2032)
  12. 4.3.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Type (2021-2032)
5 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Application
  1. 5.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Application Introduction
  2. 5.1.1 Pharmaceutical Intermediates
  3. 5.1.2 Organic Synthesis
  4. 5.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application
  5. 5.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021-2032)
  7. 5.2.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2032)
  8. 5.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application
  9. 5.3.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021-2032)
  11. 5.3.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Ningbo Innopharmchem
  2. 6.1.1 Ningbo Innopharmchem Company Information
  3. 6.1.2 Ningbo Innopharmchem Business Overview
  4. 6.1.3 Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  6. 6.1.5 Ningbo Innopharmchem Recent Developments
  7. 6.2 Manus Aktteva Biopharma
  8. 6.2.1 Manus Aktteva Biopharma Company Information
  9. 6.2.2 Manus Aktteva Biopharma Business Overview
  10. 6.2.3 Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  12. 6.2.5 Manus Aktteva Biopharma Recent Developments
  13. 6.3 Hefei Home Sunshine Pharmaceutical
  14. 6.3.1 Hefei Home Sunshine Pharmaceutical Company Information
  15. 6.3.2 Hefei Home Sunshine Pharmaceutical Business Overview
  16. 6.3.3 Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  18. 6.3.5 Hefei Home Sunshine Pharmaceutical Recent Developments
  19. 6.4 Nantong Zandery BioTechnology
  20. 6.4.1 Nantong Zandery BioTechnology Company Information
  21. 6.4.2 Nantong Zandery BioTechnology Business Overview
  22. 6.4.3 Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  24. 6.4.5 Nantong Zandery BioTechnology Recent Developments
  25. 6.5 Changzhou An Peng Chemical
  26. 6.5.1 Changzhou An Peng Chemical Company Information
  27. 6.5.2 Changzhou An Peng Chemical Business Overview
  28. 6.5.3 Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  30. 6.5.5 Changzhou An Peng Chemical Recent Developments
  31. 6.6 Changzhou uniringchem
  32. 6.6.1 Changzhou uniringchem Company Information
  33. 6.6.2 Changzhou uniringchem Business Overview
  34. 6.6.3 Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  36. 6.6.5 Changzhou uniringchem Recent Developments
  37. 6.7 Huateng Pharmaceuticals
  38. 6.7.1 Huateng Pharmaceuticals Company Information
  39. 6.7.2 Huateng Pharmaceuticals Business Overview
  40. 6.7.3 Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  42. 6.7.5 Huateng Pharmaceuticals Recent Developments
  43. 6.8 Shanghai Send Pharmaceutical
  44. 6.8.1 Shanghai Send Pharmaceutical Company Information
  45. 6.8.2 Shanghai Send Pharmaceutical Business Overview
  46. 6.8.3 Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  48. 6.8.5 Shanghai Send Pharmaceutical Recent Developments
  49. 6.9 Pharmaffiliates Analytics & Synthetics
  50. 6.9.1 Pharmaffiliates Analytics & Synthetics Company Information
  51. 6.9.2 Pharmaffiliates Analytics & Synthetics Business Overview
  52. 6.9.3 Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  54. 6.9.5 Pharmaffiliates Analytics & Synthetics Recent Developments
  55. 6.10 Biosynth Carbosynth
  56. 6.10.1 Biosynth Carbosynth Company Information
  57. 6.10.2 Biosynth Carbosynth Business Overview
  58. 6.10.3 Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  60. 6.10.5 Biosynth Carbosynth Recent Developments
  61. 6.11 ChemScene
  62. 6.11.1 ChemScene Company Information
  63. 6.11.2 ChemScene Business Overview
  64. 6.11.3 ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio
  66. 6.11.5 ChemScene Recent Developments
7 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region
  1. 7.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region (2021-2032)
  3. 7.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region (2021-2026)
  4. 7.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Forecast by Region (2027-2032)
  5. 7.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2021-2032)
  7. 7.4.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2021-2026)
  8. 7.4.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2027-2032)
  9. 7.5 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032)
  12. 7.6.2 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032)
  14. 7.6.4 South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032)
8 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region
  1. 8.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2021-2032)
  3. 8.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2021-2026)
  4. 8.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Value Chain Analysis
  2. 9.1.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Mode & Process
  6. 9.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Distributors
  9. 9.2.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst